Biomedical Sciences, PhD Program
The curriculum of the Biomedical Sciences PhD and Research Master’s Programs is currently under review. A revised curriculum is planned for 2016-2017, with the following goals: (1) Less dependence on the medical school curriculum (M.D. program); (2) Completion of most or all courses by December of Year 2; (3) Streamlining to eliminate duplication and integrate learning across disciplines.
The stipend for PhD students is currently set at $26,500
Since 1980, the Biomedical Sciences, PhD Program at Eastern Virginia Medical School has provided students with a foundation of biomedical science knowledge and intensive laboratory research training.
|Key advantages of this program:||Research focus areas include:|
Meet Matthew Butcher, Biomedical Sciences, PhD Graduate
Matt, a Biomedical Sciences PhD graduate, joined Dr. Elena Galkina’s laboratory in 2009 within the department of Microbiology and Molecular Cell Biology to work on the dynamics of leukocytes in atherosclerosis. Since then, through hard work and multiple rewarding collaborations with Dr. Nadler, Dr. Imai, Dr. Dobrian, Dr. Dobrydneva, and Dr. Han, Matt is now actively involved with projects on major health concerns in the Hampton Roads area - including type two diabetes mellitus, atherosclerosis, obesity, and chronic rhinosinusitis. As a result of his efforts, Matt’s tenure in the biomedical science PhD program has been productive and immensely rewarding. Matt has successfully co-authored four papers and is the primary author of three papers, two reviews, two book chapters, and an editorial article. Additionally, Matt has been invited to give several talks at national scientific meetings, including the American Association of Immunologists, Atherosclerosis Thrombosis and Vascular Biology, and Gordon Atherosclerosis research conferences. He was also a Health Professions Scholar and a American Heart Association mid-atlantic pre-doctoral scholar. In the future, Matt plans on continuing to pursue a career in academia, focusing primarily on bioinformatics and auto-inflammation in atherosclerosis. Matt received his PhD in February 2015 and is currently working as postdoctoral fellow in the lab of his mentor, Dr. Elena Galkina.
Kim Nguyen, Biomedical Sciences, PhD Graduate
As a Ph.D. student in the Biomedical Sciences Program, Kim worked in the lab of Dr. Patric Lundberg in the Department of Microbiology and Molecular Cell Biology, where she investigated the role of sex hormones in Herpes Simplex Virus (HSV) pathogenesis. She has discovered a novel mechanism in which the virus is regulated by sex hormones produced within the host. In our program, she has been the primary author of two manuscripts and has co-authored one manuscript in addition to two previous articles published from work on her M.S. at VCU. She has also shared her novel findings at several local and international research conferences, including the Virginia Regional Herpes Symposium, ISBiotech Conference, and the International Herpesvirus Workshop. A former Health Professions Scholar as well as Biomedical Sciences Student Organization President, she has successfully jump-started several key events including our “Faculty Presentations of Abstracts” to inform new incoming graduate students of research in EVMS labs, and a “Graduate Student Research Conference” to showcase the basic science research conducted by our students. In the future, Kim wants to continue pursue a career in academic science, with a focus on the sexual dimorphism of infectious diseases. Kim received her PhD in July 2014 and is a Scientist working on T Cell Development at Kite Pharma in Santa Monica, CA.
EVMS receives NIH grant for biomarker research
The National Cancer Institute, part of the National Institutes of Health, recently awared researchers at the EVMS Leroy T. Canoles Jr. Cancer Research Center a $2.1 million grant to continue work on a breakthrough in the area of early detection of aggressive prostate cancer. The EVMS-led research team brings together internationally recognized translational research groups from the U.S. and Canada.
“This grant will help us continue our work to develop tests that can identify aggressive prostate cancer before it advances and to realize our dream of personalized medicine that can tailor treatment decisions to fit the individual patient,” says John Semmes, PhD, Director of the cancer research center and Professor of Microbiology and Molecular Cell Biology. “We want to be able to identify advanced disease prior to surgery so that more aggressive treatment options are implemented earlier.” The EVMS group is co-led by Julius Nyalwidhe, PhD, also a member of the center and Assistant Professor of Microbiology and Molecular Cell Biology.
Woong-Ki Kim, PhD, Associate Professor of Microbiology and Molecular Cell Biology and a faculty member in the Leroy T. Canoles Jr. Cancer Research Center, was invited to present “Expression and Phosphorylation of SAMHD1 Increases with Viral Loads in the Brains of SIV-Infected Rhesus Macaques” at the 34th Annual Symposium on Nonhuman Primate Models for AIDS held Oct. 11-14 in New Orleans.
Faculty share in National Academies grant
Three EVMS faculty are among the investigators to receive research funding from the National Academies Keck Future Initiatives project. The grant was one of 11 given nationwide in 2016 to support interdisciplinary work.
Patric Lundberg, PhD, Associate Professor of Microbiology and Molecular Cell Biology; Richard Ciavarra, PhD, Professor of Microbiology and Molecular Cell Biology; and Larry Sanford, PhD, Professor of Pathology and Anatomy, are among the collaborators on the project "Design in Information Flow; Using aesthetic principles to overcome computational barriers in the analysis of complex systems."
Dr. Kim receives $3.2 million grant for HIV cure study
Woong-Ki Kim, PhD, Assistant Professor of Microbiology and Molecular Cell Biology and a faculty member in the Leroy T. Canoles Jr. Cancer Research Center, received notice of a $3.2 million award from the National Institutes of Health for an R01 project titled “Targeting Brain Macrophage Reservoirs of SIV during HAART.” The grant will fund his study to evaluate the effect of macrophage-depleting drugs on viral reservoirs for a cure of HIV, especially in the brain.
This website reflects current program information, including admissions criteria and curricula. Information is subject to change.